Recombinant Human Endostatin in Combination With XELOX Therapy in Patient With Advanced Colorectal Cancer.
Clinical trial NCT03577392 · UNKNOWN
Trial details
- NCT number
- NCT03577392
- Sponsor
- Sichuan Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2019-08-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.